The Investing News Network takes a look at the major developments from the world of biotech in 2017.
The gold price edged higher on Friday as the US dollar eased. Meanwhile, silver was on track for a weekly increase and copper was down for the week.
The gold price edged lower on Friday after the US Senate approved a budget blueprint and investors turned to riskier assets.
The gold price edged lower on Friday after a new jobs report increased worries of another rate hike from the US Federal Reserve.
The gold price has been driven mainly by geopolitical tensions and a weak US dollar in Q3, and looks set to end the period higher.
The US Federal Reserve left interest rates unchanged at this week’s meeting, but announced that it will begin reducing its balance sheet next month.
The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.
The gold price edged lower on Friday and was headed for a weekly loss after a North Korean missile test brought little reaction from investors.